QIANHAI HEALTH (00911) Announces Interim Results with Net Profit of HK$4.774 Million, Down 69.3% YoY

Stock News08-20

QIANHAI HEALTH (00911) announced its interim results for 2025, reporting revenue of approximately HK$341 million, representing an increase of 11.04% year-on-year. Net profit reached HK$4.774 million, declining 69.3% compared to the same period last year. Earnings per share stood at 2.82 HK cents.

Despite the revenue growth, gross profit for the interim period dropped significantly from approximately HK$42.9 million in the previous period to approximately HK$14.2 million. The decline in gross profit was primarily attributed to intensified market competition, which forced the group to sell electronic components products at lower gross margins.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment